AstraZeneca is the largest research-based pharmaceutical company in Canada and one of the largest pharmaceutical companies in the world. Defined by the belief that "Health Connects Us All," AstraZeneca is a company that is focused on making a meaningful difference to patients' lives through collaborations. In Canada, we invest approximately $100 million annually in research and development and charitable donations. The company employs approximately 850 people across Canada who strive to make the most meaningful difference to patient health through the discovery, development and marketing of our great medicines. Most of our Canadian employees work at our high-tech headquarters in Mississauga, Ontario, while 125 highly-skilled scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, and scientists at the facility are focused on finding new and innovative therapeutic solutions to treat acute and chronic pain. Our innovative and extensive product portfolio focuses on six key areas of medicine: gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease.
Marion McCourt, President and Chief Executive Officer
Adresse :
1004 Middlegate Road
Mississauga, ON L4Y 1M4
Canada
Numéro de téléphone :
905-566-7323
AstraZeneca Canada Inc. ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement